Vitaforest Chaga Mushroom Native Dry Extract

• Non Irradiation/Non Ionized Statement
  We hereby certify that the product has not been sterilized byionizing radiation at anypoint during the entire manufacturing process and therefore is in full compliance with the relevant legislated regulations (Directive 1999/2/CE).
• BSE/TSE Statement
  We hereby certify that the product contains no ingredients of ruminant origin and no materials derived from, or exposed to ruminants affected byor under quarantine for Transmitting Transmissible Spongiform Encephalopathy(TSE)/ Bovine Spongiform Encephalopathy (BSĖ) and it is conform to the EU legislation 999/2001.
• Packaging Statement
  We hereby certify that the packing used is in compliance with: Commission Regulation (EC)No 1935/2004 and Regulation (EU) No 10/2011 regarding packaging materials and articles intended to come into contact with food.
• Pesticide Statement
  We hereby certify, basis on our actual knowledge of production process, raw materials and equipment used potential pesticide residues in the above-mentioned product comply with the European legislation on pesticide residues, esp. Regulation (EC) No. 396/2005.
• Residual Solvent Statement
  We hereby certify that the product meets with: Directive E 2010/59/EU of 26 August 2010 amending Directive 2009/32/EC ofthe European Parliamentand of the Council on the approximation of the laws of the Member States on extraction solvents used in the production of foodstuffs and food ingredients.
• Contaminant Statement
  This is to certify that the product meets with:
  REGULATION (EC) No. 1881/2006 and subsequent amendments as concerns the maximum level admitted of the following contaminants:
  1. Aflatoxin B1
  2. Aflatoxins B1 + B2 + G1 + G2
  3. Ochratoxin
  4. Melamine

REGULATION (EC) No. 1933/2015 amending regulation (EC) No. 1881/2006 as regards maximum levels for polycyclic arom atic hydrocarbons, in particular:

1. Maximum level of 10 ug/kg of benzo(a)pyrene
2. 50 ug/kg for the sum of PAH4 (benzo(a)pyrene, chrysene, benz(a)anthracene and benzo(b)fluoranthene) in food supplements.

• Nanomaterial Statement
  According to the definition of “nanomaterials" of the EU Regulation (EU) No. 1169/2011 of the European parliament and of the council of 25 October 2011 on the provision of food information to consumers, we hereby attest that no nanomaterials are used in the formulation or in the packaging material of the product.
• Anti-Doping Statement
  As per the list of 2017 and subsequent amendments of the world anti-doping agency, the ingredient is not a doping substance and not a combination of doping substances. The ingredient does not contain any doping substance. The ingredient does not result from a doping substance.
• Expected Usage
  The expected usage ofthis product is its incorporation as an ingredientin the food industryor the pharmaceutical industry.

⁽¹⁾ Cereals which contain gluten (i.e.w heat, rye, barley, oats, spelt, kamut or their hybridized strains) except: w heat-based glucose syrups including dextrose, wheat-based maltodextrins, glucose syrups based on barley, cereals used for making distillates or ethyl alcohol of agricultural origin for spirit drinks and other alcoholic beverages.
⁽²⁾ Except: fish gelatine used as carrier for vitamin or carotenoid preparations, fish gelatine or singlass used as fining ag ent in beer and wine.
⁽³⁾ Except fully refined soybean oil and fat, natural mixed tocopheols (E306), natural D-alpha tocopherol, natural D-alpha tocopherol acetate, natural D-alpha tocopherol succinate from soybean sources;vegetable oils derived phytosterols and phytosterolesters from soybean sources; plant stanol es ter producted from vegetable oil sterols from soybean sources.
⁽⁴⁾ Except when used for making distillates or ethyl alcohol of agricultural origin for spirit drinks and other alcoholic beverages, lac tito.
⁽⁵⁾ Almond (Amydalus communis L.) hazelnuts (Corylus avellana), walnut (Juglans regia), cashew (Anacardium occidentale), pecan nuts (Carya illinaiesis), brazil nut (Bertholletia excelsa), pistachio nut (Pistacia vera), macadamia nut and queensland nut
(Macadamia terniflora) and products thereof, except nuts used for making distillates or ethyl alcohol of agricultural origin for spirit drinks and other alcoholic beverages

In accordance with the directive 1169/2011 EC.

The following ingredients produced from genetically modified organisms are present in the product: None
In accordance with the regulation (EC) No 1829/2003 and (EC) No 1830/2003 of the European Parliament

• Scientific name : Inonotus obliquus (Ach. ex Pers.) Pilat
• Synonyms : Polyporus obliquus (Ach. ex Pers.) Fr. Fomes obliquus (Ach. ex Pers.) Cooke
• Botanical family : Hymenochaetaceae
• Common names : Chaga, birch conk
• Geographical origin : Russian Federation, Siberia
   

Harvest

After Harvest

Additional Information

We have built a full production cycle - from the search and collection of raw materials, the manufacture of the product to the delivery of the order to the client's territory. This guarantees you stable prices, stable quality and continuous deliveries. We focus on the needs of our customers and, upon request, carry out additional analyzes, develop the necessary documentation. and we produce extracts and powders with the characteristics you need.

Verification : We check raw materials and final products with the help of laboratory tests at every stage from raw material preparation to finished extracts and powders. The supplied products comply with the EU safety and quality standards.

• It is effective in oncological diseases, especially affecting organs with abundant blood supply - lungs, stomach, as well as in cases excluding radiation therapy and surgical methods.
• It has an antispasmodic effect (relieves spasms of smooth muscles of internal organs)
• It protects liver cells from toxic damage
• It has an immunomodulatory effect (increases immunity), chaga increases the body's resistance to infectious diseases
• It has a diuretic effect (diuretic)
• It has anti-inflammatory properties

• It is used to treat tumors of the uterus and ovaries improves insomnia performance
• It is used for infertility treatment and treatment of mastopathy

• It is used to improve potency

• It lowers blood sugar
• It lowers arterial and venous pressure, reduces the pulse rate, regulates the activity of the cardiovascular system
• It stimulates blood formation (increases the level of leukocytes - cells responsible for immunity)

• It normalizes the activity of the gastrointestinal tract and intestinal microflora
• It contributes to the scarring of gastric and duodenal ulcers

• It is used to treat skin diseases (such as psoriasis)
• When it is used externally, chaga exhibits an anti-inflammatory, healing and analgesic effect, protects the skin from the harmful effects of the external environment, including fungal and viral infections, relieves swelling and contributes to the restoration of healthy skin.

Indications

• Oncological diseases
• Reduced immunity
• Mastopathy
• Gastrointestinal diseases
• Microflora disorders
• Psoriasis and other skin diseases

Contrindications

• Colitis
• Desentery
• Pregnancy
• Penicillin antibiotic treatment

• Ingredients are packed into double bags to avoid moisture condensation. During shipment bags are stored into double-double carton boxes.
• 10 kg/carton box